Circulate Health Secures Strategic Investment to Expand TPE Technologies and Health Innovations

Circulate Health Secures Strategic Investment from Scrum Ventures

Novato, California, December 3, 2025 - Circulate Health, recognized as a pioneering force in Therapeutic Plasma Exchange (TPE) technologies, has revealed a significant strategic investment from Scrum Ventures, a prominent venture capital firm focused on enhancing human performance and health technology. This seven-figure investment marks a crucial step in propelling Circulate Health’s growth trajectory in the healthcare industry.

Brad Younggren, CEO and Co-Founder of Circulate Health, expressed enthusiasm about the partnership, highlighting that consumers are increasingly acknowledging the invaluable benefits of TPE. He stated, "Partnering with Scrum Ventures allows us to expand our research and continue the momentum we’ve seen since inception, paving the way for a new era in healthcare."

Circulate Health's innovative platform utilizes cutting-edge TPE technology aimed at eliminating circulating microplastics, environmental toxins, inflammatory markers, and other microscopic pollutants that may be detrimental to health. Early research indicates that these particles can accumulate in the body, leading to systemic inflammation, oxidative stress, and various long-term health challenges.

Michael Proman, a partner at Scrum Ventures, emphasized the significance of this collaboration, stating, "The shift towards proactive, science-backed longevity care is a pivotal movement in modern health. Circulate is at the forefront of this transformation, developing a patient-centered platform that is scalable and impactful."

This partnership not only highlights the commitment of Circulate Health in improving health outcomes but also signifies a convergence of two rapidly evolving sectors—healthcare and environmental sustainability. The investment will allow Circulate Health to further their research and development efforts, ensuring that they remain at the cutting edge of health technology.

About Circulate Health

Backed by Khosla Ventures, Circulate Health is dedicated to revolutionizing health outcomes and longevity through innovative technologies. With a firm commitment to advancing the science behind TPE, Circulate Health is poised to lead the charge in the future of health management. To learn more, visit circulate.health.

About Scrum Ventures

Scrum Ventures operates as a seed-stage venture capital firm with bases in San Francisco and Tokyo. It invests in innovative companies across a spectrum of industries, including health, sports, mobility, and AI robotics. The firm is dedicated to supporting startups that aim to enhance athlete performance, wellness, and further the development of next-generation sports technology. For more details, explore Scrum.vc.

As Circulate Health continues to innovate in TPE, the collaboration with Scrum Ventures stands as a beacon of hope for advancements in healthcare technology and long-term wellness strategies.